Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Viral load and antibody boosting following herpes zoster diagnosis.

Warren-Gash C, Forbes H, Maple P, Quinlivan M, Breuer J.

J Clin Virol. 2018 Jun;103:12-15. doi: 10.1016/j.jcv.2018.03.010. Epub 2018 Mar 21.

2.

Differentiation between wild-type and vaccines strains of varicella zoster virus (VZV) based on four single nucleotide polymorphisms.

Jin L, Xu S, Maple PAC, Xu W, Brown KE.

Epidemiol Infect. 2017 Sep;145(12):2618-2625. doi: 10.1017/S0950268817001509. Epub 2017 Jul 27.

PMID:
28748773
4.

Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs.

Maple PA.

Vaccines (Basel). 2015 Dec 9;3(4):988-1003. doi: 10.3390/vaccines3040988. Review.

5.

Is it appropriate to use fixed assay cut-offs for estimating seroprevalence?

Kafatos G, Andrews NJ, McConway KJ, Maple PA, Brown K, Farrington CP.

Epidemiol Infect. 2016 Mar;144(4):887-95. doi: 10.1017/S0950268815001958. Epub 2015 Aug 27.

PMID:
26311119
6.

Varicella zoster immune status in children treated for acute leukemia.

Patel SR, Bate J, Maple PA, Brown K, Breuer J, Heath PT.

Pediatr Blood Cancer. 2014 Nov;61(11):2077-9. doi: 10.1002/pbc.25086. Epub 2014 May 2.

PMID:
24789692
7.

Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study.

Maple PA, Hedman L, Dhanilall P, Kantola K, Nurmi V, Söderlund-Venermo M, Brown KE, Hedman K.

J Clin Microbiol. 2014 Mar;52(3):947-56. doi: 10.1128/JCM.02613-13. Epub 2014 Jan 8.

8.

Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England.

Field N, Amirthalingam G, Waight P, Andrews N, Ladhani SN, van Hoek AJ, Maple PA, Brown KE, Miller E.

Vaccine. 2014 Feb 26;32(10):1213-7. doi: 10.1016/j.vaccine.2013.06.098. Epub 2013 Jul 16.

9.

Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples.

Maple PA, Beard S, Parry RP, Brown KE.

Transfusion. 2013 Oct;53(10 Pt 2):2575-84. doi: 10.1111/trf.12278. Epub 2013 May 30.

PMID:
23721256
11.

Follow-up of pregnant women exposed to chicken pox: an audit of relationship between level of antibody and development of chicken pox.

Boxall EH, Maple PA, Rathod P, Smit E.

Eur J Clin Microbiol Infect Dis. 2011 Oct;30(10):1193-200. doi: 10.1007/s10096-011-1211-4. Epub 2011 Apr 1.

PMID:
21455665
12.

Evaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workers.

McDonald SL, Maple PA, Andrews N, Brown KE, Ayres KL, Scott FT, Al Bassam M, Gershon AA, Steinberg SP, Breuer J.

J Virol Methods. 2011 Mar;172(1-2):60-5. doi: 10.1016/j.jviromet.2010.12.021. Epub 2010 Dec 28.

13.

Characterization of Treponema pallidum particle agglutination assay-negative sera following screening by treponemal total antibody enzyme immunoassays.

Maple PA, Ratcliffe D, Smit E.

Clin Vaccine Immunol. 2010 Nov;17(11):1718-22. doi: 10.1128/CVI.00102-10. Epub 2010 Sep 15.

14.

Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults.

Molton J, Smith C, Chaytor S, Maple P, Brown K, Johnson M, Geretti AM.

J Infect. 2010 Jul;61(1):73-80. doi: 10.1016/j.jinf.2010.04.004. Epub 2010 Apr 18.

PMID:
20403382
15.

Prevalence of anti-varicella-zoster virus antibodies in French infants under 15 months of age.

Pinquier D, Gagneur A, Balu L, Brissaud O, Gras Le Guen C, Hau-Rainsard I, Mory O, Picherot G, De Pontual L, Stephan JL, Maple P, Breuer J, Aubert M, Caulin E, Sana C, Pradat P, Soubeyrand B, Reinert P.

Clin Vaccine Immunol. 2009 Apr;16(4):484-7. doi: 10.1128/CVI.00397-08. Epub 2009 Jan 28.

16.
17.

Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya.

Cumberland P, Shulman CE, Maple PA, Bulmer JN, Dorman EK, Kawuondo K, Marsh K, Cutts FT.

J Infect Dis. 2007 Aug 15;196(4):550-7. Epub 2007 Jun 29.

PMID:
17624840
18.

Application of a noninvasive oral fluid test for detection of treponemal IgG in a predominantly HIV-infected population.

Maple PA, Simms I, Kafatos G, Solomou M, Fenton K.

Eur J Clin Microbiol Infect Dis. 2006 Dec;25(12):743-9.

PMID:
17061098
20.

An oral fluid test for syphilis.

Baguley SD, Horner PJ, Maple PA, Stephenson L.

Int J STD AIDS. 2005 Apr;16(4):299-301.

PMID:
15899083
21.

The seroepidemiology of Bordetella pertussis infection in Western Europe.

Pebody RG, Gay NJ, Giammanco A, Baron S, Schellekens J, Tischer A, Olander RM, Andrews NJ, Edmunds WJ, Lecoeur H, Lévy-Bruhl D, Maple PA, de Melker H, Nardone A, Rota MC, Salmaso S, Conyn-van Spaendonck MA, Swidsinski S, Miller E.

Epidemiol Infect. 2005 Feb;133(1):159-71.

22.

Laboratory diagnosis of pertussis infections: the role of PCR and serology.

Fry NK, Tzivra O, Li YT, McNiff A, Doshi N, Maple PA, Crowcroft NS, Miller E, George RC, Harrison TG.

J Med Microbiol. 2004 Jun;53(Pt 6):519-25.

PMID:
15150332
23.

Sero-epidemiology of Bordetella pertussis in England and Wales.

Nardone A, Pebody RG, Maple PA, Andrews N, Gay NJ, Miller E.

Vaccine. 2004 Mar 12;22(9-10):1314-9.

PMID:
15003661
24.

European Sero-Epidemiology Network: standardisation of the assay results for pertussis.

Giammanco A, Chiarini A, Maple PA, Andrews N, Pebody R, Gay N, Olander RM, Fivet-Groyne F, Baron S, Tischer A, Swidsinski S, Schellekens J, Reizenstein E.

Vaccine. 2003 Dec 8;22(1):112-20.

PMID:
14604578
27.

The prevention of tetanus in England and Wales.

Maple PA, al-Wali W.

Commun Dis Public Health. 2001 Jun;4(2):106-13. Review.

PMID:
11524997
28.

The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network.

Edmunds WJ, Pebody RG, Aggerback H, Baron S, Berbers G, Conyn-van Spaendonck MA, Hallander HO, Olander R, Maple PA, Melker HE, Olin P, Fievret-Groyne F, Rota C, Salmaso S, Tischer A, von-Hunolstein C, Miller E.

Epidemiol Infect. 2000 Aug;125(1):113-25. Erratum in: Epidemiol Infect 2001 Apr;126(2):331.

29.

Immunity to diphtheria and tetanus in England and Wales.

Maple PA, Jones CS, Wall EC, Vyseb A, Edmunds WJ, Andrews NJ, Miller E.

Vaccine. 2000 Sep 15;19(2-3):167-73.

PMID:
10930669
30.

European sero-epidemiology network: standardisation of the results of diphtheria antitoxin assays.

von Hunolstein C, Aggerbeck H, Andrews N, Berbers G, Fievet-Groyne F, Maple PA, Olander RM, Raux M, Tischer A.

Vaccine. 2000 Aug 1;18(28):3287-96.

PMID:
10869774
31.

Diphtheria immunity in adults.

Maple PA, George RC, Miller E, Morgan-Capner P, Hayward P.

Lancet. 1996 Oct 5;348(9032):964. No abstract available.

PMID:
8843837
32.

Diphtheria immunity in UK blood donors.

Maple PA, Efstratiou A, George RC, Andrews NJ, Sesardic D.

Lancet. 1995 Apr 15;345(8955):963-5.

PMID:
7715300
33.

The in-vitro susceptibilities of toxigenic strains of Corynebacterium diphtheriae isolated in northwestern Russia and surrounding areas to ten antibiotics.

Maple PA, Efstratiou A, Tseneva G, Rikushin Y, Deshevoi S, Jahkola M, Vuopio-Varkila J, George RC.

J Antimicrob Chemother. 1994 Dec;34(6):1037-40.

PMID:
7730218
34.

Hepatitis C virus infections in transplant patients: serological and virological investigations.

Maple PA, McKee T, Desselberger U, Wreghitt TG.

J Med Virol. 1994 Sep;44(1):43-8.

PMID:
7798884
35.
36.

Activities of newer fluoroquinolones against Shigella sonnei.

John JF Jr, Atkins LT, Maple PA, Bratoeva M.

Antimicrob Agents Chemother. 1992 Oct;36(10):2346-8.

38.

In vitro assessment of rokitamycin against problem gram-positive cocci.

Hamilton-Miller JM, Maple PA.

J Chemother. 1992 Feb;4(1):6-8.

PMID:
1403073
39.

Bacteriological safety of cook-chill food at the Royal Free Hospital, with particular reference to Listeria.

Chudasama Y, Hamilton-Miller JM, Maple PA.

J Hosp Infect. 1991 Dec;19(4):225-30.

PMID:
1686034
40.

Ceftazidime-resistant Klebsiella pneumoniae.

MacDonald AA, Maple PA, Kibbler CC, George RC, Johnson AP, Du Bois SK, Amyes SG.

Lancet. 1991 Jun 29;337(8757):1609-10. No abstract available.

PMID:
1675738
41.

Revised MRSA guidelines: is the use of ciprofloxacin against MRSA a cause for concern?

Maple PA, Hamilton-Miller JM.

J Hosp Infect. 1991 May;18(1):77-8. No abstract available.

PMID:
1679077
42.
43.

A review of the antimicrobial activity of the fluoroquinolones.

Maple P, Brumfitt W, Hamilton-Miller JM.

J Chemother. 1990 Oct;2(5):280-94. Review.

PMID:
2128638
44.

Ramoplanin versus methicillin-resistant Staphylococcus aureus: in vitro experience.

Brumfitt W, Maple PA, Hamilton-Miller JM.

Drugs Exp Clin Res. 1990;16(8):377-83.

PMID:
2097143
45.

Ciprofloxacin resistance in methicillin- and gentamicin-resistant Staphylococcus aureus.

Maple P, Hamilton-Miller J, Brumfitt W.

Eur J Clin Microbiol Infect Dis. 1989 Jul;8(7):622-4.

PMID:
2506023
47.

World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.

Maple PA, Hamilton-Miller JM, Brumfitt W.

Lancet. 1989 Mar 11;1(8637):537-40.

PMID:
2564067
48.

Diffuse lung infiltration in a homosexual man without AIDS.

Pohil R, Maple P, D'Alonzo G.

J Am Osteopath Assoc. 1988 Sep;88(9):1115-7. No abstract available.

PMID:
3262609
49.

Lithium prevention of amphetamine-induced 'manic' excitement and of reserpine-induced 'depression' in mice: possible role of 2-phenylethylamine.

Borison RL, Sabelli HC, Maple PJ, Havdala HS, Diamond BI.

Psychopharmacology (Berl). 1978 Dec 8;59(3):259-62.

PMID:
104329
50.

Metabolism of an amino acid with antidepressant properties.

Borison RL, Maple PJ, Havdala HS, Diamond BI.

Res Commun Chem Pathol Pharmacol. 1978 Aug;21(2):363-6.

PMID:
694233

Supplemental Content

Support Center